Bone Tumors Explained: Benign vs Malignant, Key Types, Imaging Signs and Treatments

Overview

This Osmosis video explains bone tumors, distinguishing benign from malignant lesions, and detailing the most common tumor types, their biology, and how they are diagnosed and treated.

Key insights

• Benign tumors such as osteochondroma and giant cell tumor arise from bone cells or osteoclasts and have characteristic imaging features.
• Malignant primary bone tumors include osteosarcoma, Ewing sarcoma, and chondrosarcoma, each with distinct cellular origins and age distributions.
• Genetic mutations play crucial roles, including RB1 and TP53 in osteosarcoma and the EWSR1-FLI1 translocation in Ewing sarcoma.
• Radiographic signs such as sunburst appearance, onion-skin layering, exostoses, and soap-bubble lesions aid in diagnosis, complemented by CT and MRI.
• Treatment ranges from surgical removal for benign tumors to radiotherapy, chemotherapy, and surgery for malignant tumors depending on type and spread.

Introduction to Bone Tumors

The video provides a comprehensive overview of bone tumors, explaining that tumors can be benign or malignant, and that primary bone tumors can arise from bone-forming cells (osteoblasts), bone-resorbing cells (osteoclasts), or primitive bone marrow cells. It emphasizes how growth, development, and metastasis influence presentation and prognosis, and it names the most common sites and radiographic patterns associated with each tumor type.

Bone Biology and Pathogenesis

The material reviews normal bone cell function, including osteoblasts that build bone and osteoclasts that resorb bone, and notes how mutations in protooncogenes and tumor suppressor genes disrupt normal cell cycle control. Key players mentioned are RB1 and TP53, with Li Fraumeni syndrome and familial retinoblastoma linked to osteosarcoma risk. The discussion also covers how secondary bone tumors can seed the bones from distant sites via the bloodstream or lymphatic system, with common primaries including breast, prostate, lung, kidney, thyroid, and brain cancers.

Benign Bone Tumors

The video highlights several benign entities, focusing first on osteochondroma, which arises from growth plate mutations (EXT1 and EXT2) and forms a lateral bony projection with a cartilage cap (exostosis). It also describes osteoid osteomas and osteoblastomas, which feature a nidus within bone, with the nidus size and surrounding sclerosis helping to distinguish them. Giant cell tumors are described as arising in the epiphysis and containing numerous nuclei in tumor cells, sometimes following trauma or radiation exposure. The review notes that these lesions may cause symptoms such as nerve compression or bone erosion but are generally non-metastatic.

Malignant Primary Bone Tumors

The speaker then covers malignant tumors, focusing on osteosarcoma, Ewing sarcoma, and chondrosarcoma. Osteosarcoma is described as a pleomorphic tumor producing excessive osteoid, often arising in the metaphysis of rapidly dividing bones during adolescence. Ewing sarcoma is characterized by neuroectodermal, small round blue cells and a characteristic EWSR1-FLI1 translocation. It typically affects the femur and tibia in adolescence. Chondrosarcoma, more common in older adults, arises from chondrocytes and frequently involves the pelvis, with imaging showing medullary involvement.

Genetics and Molecular Features

Important genetic associations include RB1 and TP53 mutations linked to osteosarcoma, and the EWSR1-FLI1 fusion seen in Ewing sarcoma. These molecular events contribute to abnormal differentiation and tumor formation in bone tissue. The video also mentions how rapid bone growth and a positive family history can be risk factors, alongside radiation exposure and prior bone trauma for certain tumors.

Imaging and Diagnosis

Diagnosis begins with X-ray, CT, and MRI, with serum tumor markers assisting in identifying tumor type. Classic radiographic patterns are discussed: exostoses for osteochondroma, soap-bubble appearance for giant cell tumors, sunburst patterns for osteosarcoma, onion-skin periosteal reactions in Ewing sarcoma, and moth-eaten bone destruction in chondrosarcoma. The content stresses that imaging is complemented by clinical symptoms such as persistent bone pain, swelling, fractures, nighttime pain for osteoid osteoma, and neurological symptoms from nerve impingement in some tumors. Lung metastases are a common concern in malignant disease and guide staging and management.

Treatment and Management

Treatment strategies differ by whether a tumor is benign or malignant. Benign tumors are typically managed with surgical excision to relieve pain and reduce fracture risk. Malignant tumors require a combination of radiotherapy, chemotherapy, and surgical resection, tailored to the tumor type, location, and extent of spread. The video recaps the key benign and malignant entities with their defining imaging and histology features to aid diagnosis and treatment planning.

Takeaway Recap

• Osteochondroma, giant cell tumor, osteoid osteoma, and osteoblastoma are common benign bone tumors with characteristic growth patterns and radiographic features.
• Osteosarcoma, Ewing sarcoma, and chondrosarcoma are the principal malignant bone tumors, each with unique cellular origins and genetic markers.
• Imaging findings such as sunburst, onion-skin, exostosis, and soap bubbles are crucial clues in diagnosis, supported by genetic testing where applicable.
• Treatment hinges on tumor biology and spread, spanning surgery for benign lesions to a combination of chemotherapy, radiotherapy, and surgery for malignant disease.

Context

Content is presented within the Osmosis platform, with emphasis on clinical relevance, imaging interpretation, and the genetic underpinnings of bone tumors.